Molzym Announces Double-Digit Million EUR Capital Increase
Molzym is proud to announce a double-digit million EUR investment by a large single family office.
The capital will be deployed for the international business expansion, in particular for market entry and expansion in the US and China as well as further expanding its presence in Europe. Fur ... more
Molzym is Part of Gradian Diagnostics
Gradian Diagnostics announced that Molzym GmbH & Co. KG is joining Gradian Diagnostics. Molzym will become the first acquisition, bringing a wide set of products and services due to their wealth of experience and expertise in molecular microbial analysis, and their focus on deep research an ... more
Molzym Automated Pathogen Enrichment and PCR Test Gets CE Mark for In Vitro Diagnostics
Molzym announces CE IVD marking of their robotic microbial DNA isolation and direct PCR test, Micro-Dx™, for routine pathogen diagnosis.
With Micro-Dx™ Molzym introduces its latest development of products in line with SepsiTest™-UMD which was released in 2008.
“By Molzym’s proprietary robot ... more